| Role |
Name |
Disclosure |
Details |
| Author | Norberto Alvarez, MD, Assistant Professor, Department of Neurology, Harvard Medical School; Consulting Staff, Department of Neurology, Boston Children's Hospital | Nothing to disclose | Details | | Medical Editor | Michael J Schneck, MD, Associate Professor, Department of Neurology and Neurosurgery, Loyola University Chicago, Stritch School of Medicine | boehringer-ingelheim sanofi/bms pfizer genentech ucb pharma talecris nmt medical NIH vernalis sanofi boehringer-ingelheim photophera inc | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Kenneth J Mack, MD, PhD, Senior Associate Consultant, Department of Child and Adolescent Neurology, Mayo Clinic | Nothing to disclose | Details | | CME Editor | Matthew J Baker, MD, Consulting Staff, Collier Neurologic Specialists, Naples Community Hospital | Nothing to disclose | Details | | Chief Editor | Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Kenneth J Mack, Managing Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Matthew J Baker, CME Editor |
The contributor discloses no conflict of interest. |
|